Therapeutic Potential of Inorganic Nanoparticles for the Delivery of Monoclonal Antibodies

Journal of Nanomaterials - United States
doi 10.1155/2015/309602
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Hindawi Limited

Related search

Cell Delivery of Therapeutic Nanoparticles

Progress in Molecular Biology and Translational Science
Molecular MedicineMolecular Biology
2011English

Therapeutic Potential of Deglycosylated Antibodies

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2013English

Integrated Flow-Through Purification for Therapeutic Monoclonal Antibodies Processing

mAbs
AllergyImmunology
2018English

Effect of Kinase Inhibitors on the Therapeutic Properties of Monoclonal Antibodies

mAbs
AllergyImmunology
2015English

Activatable Protein Nanoparticles for Targeted Delivery of Therapeutic Peptides

Advanced Materials
Mechanics of MaterialsMaterials ScienceNanotechnologyMechanical EngineeringNanoscience
2018English

Characterization of Conformation-Specific, Human-Derived Monoclonal Antibodies Against TTR Aggregates With Potential for Diagnostic and Therapeutic Use

Orphanet Journal of Rare Diseases
MedicineGeneticsPharmacology
2015English

Multifunctional Inorganic Nanoparticles for Imaging, Targeting, and Drug Delivery

ACS Nano
Materials ScienceNanoscienceEngineeringNanotechnologyAstronomyPhysics
2008English

The Safety of Therapeutic Monoclonal Antibodies: Implications for Cancer Therapy Including Immuno-Checkpoint Inhibitors

Physiological Research
MedicinePhysiology
2016English

Monoclonal Antibodies for the Treatment of Cancer

Anticancer Research
MedicineCancer ResearchOncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy